Tag: biosimilars

Addressing Patient Concerns About Biosimilars: Reducing Hesitation
Addressing Patient Concerns About Biosimilars: Reducing Hesitation
Graham Everly May 21, 2026

Explore why patients hesitate to use biosimilars and how to overcome fears. Learn the key differences between biosimilars and generics, understand safety data, and discover strategies to build confidence in these cost-effective biologic alternatives.

How to Reduce Costs for Specialty Medications and Injectables: 2026 Strategies
How to Reduce Costs for Specialty Medications and Injectables: 2026 Strategies
Graham Everly February 4, 2026

Learn proven strategies to lower costs for specialty medications and injectables. From biosimilars to formulary management, discover actionable steps employers and patients can take to save money without compromising care.

Specialty Pharmacy and Generics: Unique Practice Considerations for Pharmacists
Specialty Pharmacy and Generics: Unique Practice Considerations for Pharmacists
Graham Everly December 17, 2025

Specialty pharmacy handles high-cost, complex drugs for chronic conditions. As generics and biosimilars enter this space, pharmacists must balance cost savings with patient safety, tracking excipients, managing PBM pressures, and educating patients through every switch.

Provider Education: Understanding Biosimilar Differences
Provider Education: Understanding Biosimilar Differences
Graham Everly November 15, 2025

Biosimilars offer major cost savings but are often confused with generics. Learn how they differ, why provider education is critical, and what you need to know to use them safely and effectively.